As is the case with other biomarker studies, the functional backgrounds of biomarker molecules remain unclear yet but it would be useful to investigate the functional properties of secernin-1 and GST-P1 in the malignant features of synovial sarcoma, in parallel with validation studies. Here, SCRN1 is linked to synovial sarcoma.